Stanislav Glezer - Aug 9, 2021 Form 4 Insider Report for Inogen Inc (INGN)

Role
EVP, Chief Medical Officer
Signature
/s/ Alison Bauerlein, as Attorney-in-Fact
Stock symbol
INGN
Transactions as of
Aug 9, 2021
Transactions value $
$0
Form type
4
Date filed
8/11/2021, 09:21 AM
Previous filing
Jun 21, 2021
Next filing
Mar 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INGN Restricted Stock Unit Award $0 +12.3K $0.00 12.3K Aug 9, 2021 Common Stock 12.3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F2 Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.